EUVIMEDOpdag EUVIMED
Multizentrische StudieOpen access · CC BY 4.0

D‐Alloantibody Titration Assessment Study: In Search of a Common Antibody Titration Platform—A BEST Collaborative Study

Fatima A Aldarweesh iD, Rim Abdallah, Ingrid Perez Alvarez, Jennifer Andrews, Therese M Chlebeck, Jessica Clower, Aisling Costelloe, Dolores Figueroa, Chloe George, Michael Evans, Sarah Ilstrup, Ellen B Klapper and 7 more

Transfusion · 2026

DOI: 10.1111/trf.70022 ↗

At a glance

Multizentrische Studie in Transfusion, 2026. Written by Fatima A Aldarweesh and 18 co-authors. Institution: Department of Pathology, University of Chicago, Chicago, Illinois, USA. Major MEDLINE topics: Isoantibodies, Rh-Hr Blood-Group System. Cited 1 times so far (Crossref); 24 references. The full text is freely available (open access, CC BY 4.0). Funded by: NCATS NIH HHS, QuidelOrtho, National Institutes of Health's National Center for Advancing Translational Sciences.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Alloimmunization against D‐antigen can cause severe Hemolytic Disease of the Fetus and Newborn (HDFN). Traditionally, anti‐D‐titers are measured using a saline indirect antiglobulin test (tube testing). Anti‐D‐titers ≥8 during pregnancy trigger an escalation in maternal care. Tube testing is labor‐intensive and known for imprecision. Automated gel‐based titration is more sensitive and precise than tube titration for the detection of anti‐D. A gel titer correlated with potential fetal anemia has not been established, as studies comparing gel and tube titers provide widely variable results. This multicenter study tested anti‐D samples in parallel to characterize the difference in sensitivity between tube and automated gel assays. Study Design and Methods Patients alloimmunized to RhD had samples tested using tube and automated gel titration methods. A total of 647 samples were tested in parallel. A subset of 141 samples also had anti‐D levels quantified using continuous flow analysis (CFA). Controlled lots of R 2 R 2 red blood cells and standardized reagents were utilized.

Results

Results demonstrated that gel‐based methods yielded mean titers 2.5–3 dilutions higher than tube; this difference diminished at tube titers >128. Notably, several samples previously considered negative by tube were positive by gel. Anti‐D levels quantified by CFA demonstrated a good correlation with tube and gel testing ( R = 0.75–0.9 for tube; R = 0.85–0.89 for gel).

Discussion

A tube titer of 8 to 16 correlates with an automated gel titer of 32–128 when R 2 R 2 cells are used. Results using the CFA method correlate well with tube and gel analyses.

Subjects

MeSH terms (MEDLINE)

IsoantibodiesRh-Hr Blood-Group SystemHumansFemalePregnancyCoombs TestErythroblastosis, FetalInfant, NewbornRho(D) Immune Globulin

Author keywords

D‐antigenRhalloimmunizationantibody titergel‐based testinghemolytic disease of the fetus and newborn (HDFN)prenatal screeningtube testing

Substances

IsoantibodiesRh-Hr Blood-Group SystemRHO(D) antibodyRho(D) antigenRho(D) Immune Globulin

Authors and institutions

  • Department of Pathology, University of Chicago, Chicago, Illinois, USA.
  • Vitalant, Scottsdale, Arizona, USA.
  • Cedars Sinai, Los Angeles, California, USA.
  • Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota, USA.
  • Irish Blood Transfusion Service, Dublin, Ireland.

ORCID profiles: Fatima A Aldarweesh, Claudia S Cohn

Funding

  • NCATS NIH HHS
  • QuidelOrtho
  • National Institutes of Health's National Center for Advancing Translational Sciences

Cite

APA

Aldarweesh, F. A., Abdallah, R., Alvarez, I. P., Andrews, J., Chlebeck, T. M., Clower, J., Costelloe, A., Figueroa, D., George, C., Evans, M., Ilstrup, S., Klapper, E. B., Mueller, A., Peterson, H., Rees, T., Seo, J., Takang, A. N., Cohn, C. S., & Biomedical Excellence for Safer Transfusion (BEST) Collaborative (2026). D‐Alloantibody Titration Assessment Study: In Search of a Common Antibody Titration Platform—A BEST Collaborative Study. Transfusion. https://doi.org/10.1111/trf.70022

Vancouver

Aldarweesh FA, Abdallah R, Alvarez IP, Andrews J, Chlebeck TM, Clower J, et al. D‐Alloantibody Titration Assessment Study: In Search of a Common Antibody Titration Platform—A BEST Collaborative Study. Transfusion. 2026. doi:10.1111/trf.70022

BibTeX
@article{Aldarweesh2026,
  author = {Aldarweesh, Fatima A and Abdallah, Rim and Alvarez, Ingrid Perez and Andrews, Jennifer and Chlebeck, Therese M and Clower, Jessica and Costelloe, Aisling and Figueroa, Dolores and George, Chloe and Evans, Michael and Ilstrup, Sarah and Klapper, Ellen B and Mueller, Angela and Peterson, Hannah and Rees, Terry and Seo, Jina and Takang, Arrey N and Cohn, Claudia S and Biomedical Excellence for Safer Transfusion (BEST) Collaborative, Biomedical Excellence for Safer Transfusion (BEST) Collaborative},
  title = {D‐Alloantibody Titration Assessment Study: In Search of a Common Antibody Titration Platform—A BEST Collaborative Study},
  journal = {Transfusion},
  year = {2026},
  doi = {10.1111/trf.70022}
}
Start for free →